Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Iterum Therapeutics (ITRM.US)$ Iterum Therapeutics () plc a...

$Iterum Therapeutics (ITRM.US)$ Iterum Therapeutics () plc announced that the U.S. Food and Drug Administration has approved Iterum’s new drug application for Orlynvah for the treatment of uncomplicated urinary tract infections, or uUTIs, caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
Translate
Report
4722 Views
Comment
Sign in to post a comment
19Followers
2Following
282Visitors
Follow